Effects of esomeprazole on sleep in patients with gastroesophageal reflux disease as assessed on actigraphy

Internal Medicine
Keiko HiramotoTetsuo Arakawa

Abstract

Gastroesophageal reflux disease (GERD) is strongly associated with sleep disturbances. Although treatment with proton pump inhibitors (PPIs) helps to improve GERD symptoms and subjective sleep parameters, the effects of PPI therapy on objective sleep parameters are conflicting. The aim of this study was to examine the effects of esomeprazole treatment on GERD symptoms and sleep parameters assessed using actigraphs and questionnaires. Thirteen patients with GERD received 20 mg of esomeprazole once daily for two weeks. The patients wore actigraphs from three days before the initiation of PPI treatment to the end of therapy. They were also asked to answer the following self-reported questionnaires: Frequency Scale for the Symptoms of GERD (FSSG), Pittsburg Sleep Quality Index (PSQI) and Epworth Sleepiness Scale (ESS). Objective sleep parameters were evaluated using actigraphy. Treatment with esomeprazole significantly decreased the total FSSG score, including the scores for reflux and dysmotility, as well as the ESS score, although it had no effect on the PSQI score. After the second week of treatment, esomeprazole significantly decreased the wake time (from 47.5±39.6 min to 36.0±27.1 min) and sleep latency period (from 19.5±19.8 ...Continue Reading

References

Feb 1, 1980·The Journal of Clinical Investigation·J DentD J Petrie
Jun 14, 2003·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·C ViolaniL Ferini Strambi
Nov 27, 2004·Journal of Gastroenterology·Motoyasu KusanoMasatomo Mori
Feb 1, 2005·Alimentary Pharmacology & Therapeutics·W C OrrJ Robert
Aug 16, 2005·Alimentary Pharmacology & Therapeutics·A J Dimarino JrS Cohen
Aug 25, 2006·The American Journal of Gastroenterology·Nimish VakilUNKNOWN Global Consensus Group
May 25, 2007·Sleep·Timothy MorgenthalerUNKNOWN American Academy of Sleep Medicine
Apr 15, 2009·Journal of Gastroenterology·Yasuhiro Fujiwara, Tetsuo Arakawa
Mar 20, 2010·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·S KuribayashiM Mori
Jul 14, 2010·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Choo Hean PohRonnie Fass
Apr 14, 2011·Digestive Diseases and Sciences·Tetsuya MuraoYutaka Sasaki
May 18, 2012·Journal of Gastroenterology·Yasuhiro FujiwaraRonnie Fass
Aug 23, 2012·Journal of Gastroenterology·Nobuyuki MatsukiTakeshi Azuma
Jun 8, 2014·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Laya NasrollahRonnie Fass
Jun 20, 2014·Clinical and Translational Gastroenterology·Masahito AimiYoshikazu Kinoshita

❮ Previous
Next ❯

Citations

Oct 28, 2016·Annals of the New York Academy of Sciences·Jung Hwan Oh
May 2, 2020·The American Journal of Gastroenterology·Kelly ShepherdPeter Eastwood

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.